THE hurdles that pharmaceutical companies face in accessing global markets may now ease. The drug regulator's office is likely to extend the tenure of export licence and other approvals from one year to at least three years. The move is expected to help many pharma companies that export huge quantities by reducing compliance cost.
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/pharma-cos-may-get-export-licence-three-years
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/economic-times-new-delhi
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/exports
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
